| Schedule of antidilutive shares |
| |
|
September
30, |
|
| |
|
2018 |
|
|
2017 |
|
| Restricted stock units |
|
|
40,000 |
|
|
|
57,000 |
|
| Options to purchase common stock |
|
|
1,516,000 |
|
|
|
1,393,000 |
|
| Warrants to purchase common stock |
|
|
1,375,000 |
|
|
|
1,332,000 |
|
| |
|
|
2,931,000 |
|
|
|
2,782,000 |
|
|
| Disaggregated Revenue by Source |
| |
|
Three
Months Ended September
30,
|
|
|
Six
Months Ended September
30,
|
|
| |
|
2018 |
|
|
2017 |
|
|
2018 |
|
|
2017 |
|
| Product |
|
|
|
|
|
|
|
|
|
|
|
|
| Human Skin Care |
|
$ |
4,074,000 |
|
|
$ |
3,775,000 |
|
|
$ |
7,628,000 |
|
|
$ |
6,939,000 |
|
| Animal Skin Care |
|
|
561,000 |
|
|
|
369,000 |
|
|
|
1,102,000 |
|
|
|
808,000 |
|
| |
|
|
4,635,000 |
|
|
|
4,144,000 |
|
|
|
8,730,000 |
|
|
|
7,747,000 |
|
| Service |
|
|
304,000 |
|
|
|
181,000 |
|
|
|
578,000 |
|
|
|
413,000 |
|
| Total |
|
$ |
4,939,000 |
|
|
$ |
4,325,000 |
|
|
$ |
9,308,000 |
|
|
$ |
8,160,000 |
|
|